Qube Research & Technologies LTD Akebia Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

$91.4 Billion
Q3 2025

A detailed history of Qube Research & Technologies LTD transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 3,206,184 shares of AKBA stock, worth $5.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,206,184

Previous 1,714,544 87.0%

Holding current value

$5.45 Million

Previous $6.24 Million 38.72%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$2.7 - $4.01 $4.03 Million - $5.98 Million	1,491,640 Added 87.0%	3,206,184 $8.66 Million
Q2 2025 Aug 14, 2025	BUY	$1.55 - $3.97 $1 Million - $2.57 Million	646,267 Added 60.5%	1,714,544 $6.24 Million
Q1 2025 May 15, 2025	SELL	$1.69 - $2.84 $208,008 - $349,552	-123,082 Reduced 10.33%	1,068,277 $2.05 Million
Q4 2024 Feb 14, 2025	SELL	$1.26 - $2.13 $166,786 - $281,948	-132,370 Reduced 10.0%	1,191,359 $2.22 Million
Q3 2024 Nov 14, 2024	SELL	$0.94 - $1.55 $395,633 - $652,374	-420,887 Reduced 24.12%	1,323,729 $1.75 Million

Q2 2024 Aug 14, 2024	SELL	$0.86 - $1.63 $445,531 - $844,437	-518,060 Reduced 22.9%	1,744,616 $1.78 Million
Q1 2024 May 14, 2024	BUY	$1.27 - $2.24 $2.55 Million - $4.49 Million	2,005,503 Added 779.83%	2,262,676 $4.14 Million
Q4 2023 Feb 13, 2024	BUY	$0.8 - $1.28 $108,605 - $173,768	135,757 Added 111.81%	257,173 $318,000
Q3 2023 Nov 13, 2023	SELL	$0.87 - $1.84 $273,922 - $579,329	-314,853 Reduced 72.17%	121,416 $138,000
Q2 2023 Aug 14, 2023	BUY	$0.51 - $1.43 $222,497 - $623,864	436,269 New	436,269 $401,000
Q4 2022 Feb 14, 2023	SELL	$0.25 - $0.58 $48,725 - $113,041	-194,900 Reduced 92.92%	14,855 $8,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $0.46 $116,587 - $178,767	-388,624 Reduced 64.95%	209,755 $66,000
Q2 2022 Aug 15, 2022	BUY	$0.32 - $0.67 $191,481 - $400,913	598,379 New	598,379 $211,000
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.88 $97,675 - $161,268	-41,564 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.83 - $4.2 $117,626 - $174,568	41,564 New	41,564 $158,000
Q3 2020 Nov 12, 2020	SELL	$2.39 - $13.08 $51,662 - $282,737	-21,616 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $144,178 - $293,545	21,616 New	21,616 $294,000

Others Institutions Holding AKBA

# of Institutions

189

Shares Held

121M

Call Options Held

267K

Put Options Held

280K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $313M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Akebia Therapeutics, Inc. Transaction History